Is Aligos Therapeutics, Inc. technically bullish or bearish?

Sep 20 2025 08:06 PM IST
share
Share Via
As of September 2, 2025, Aligos Therapeutics, Inc. shows a mildly bearish technical trend despite some positive momentum indicators, with a year-to-date return of -74.92% compared to the S&P 500's 12.22%.
As of 2 September 2025, the technical trend for Aligos Therapeutics, Inc. has changed from mildly bullish to mildly bearish. Currently, the weekly MACD is mildly bullish, while the monthly MACD is also mildly bullish, indicating some positive momentum. However, the daily moving averages are mildly bearish, suggesting short-term weakness. The Bollinger Bands show a mildly bullish stance on the weekly chart but are bearish on the monthly chart, indicating mixed signals. The KST is bullish weekly but bearish monthly, and the OBV is mildly bearish on the weekly timeframe.

In terms of performance, Aligos has significantly underperformed compared to the S&P 500, with a year-to-date return of -74.92% versus the S&P's 12.22%, and a one-year return of -29.45% compared to the S&P's 17.14%. Overall, the technical stance is mildly bearish, reflecting short-term weakness despite some longer-term bullish indicators.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Aligos Therapeutics, Inc. overvalued or undervalued?
Sep 20 2025 06:39 PM IST
share
Share Via
Is Aligos Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:18 AM IST
share
Share Via
What does Aligos Therapeutics, Inc. do?
Jun 22 2025 07:01 PM IST
share
Share Via
How big is Aligos Therapeutics, Inc.?
Jun 22 2025 06:14 PM IST
share
Share Via